Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Coherus BioSciences Inc (NASDAQ:CHRS)

15.65
Delayed Data
As of Jun 23
 -0.15 / -0.95%
Today’s Change
14.00
Today|||52-Week Range
31.98
-44.40%
Year-to-Date

Today’s Trading

Previous close15.80
Today’s open15.90
Day’s range15.55 - 16.08
Volume1,117,877
Average volume (3 months)686,379
Market cap$802.7M
Dividend yield--
Data as of 4:00pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)+49.42%
Earnings growth (this year)-42.23%
Earnings growth (next 5 years)--
Revenue growth (last year)+532.82%
P/E ratioNM
Price/Sales6.21
Price/Book34.92

Competitors

 Today’s
change
Today’s
% change
NDRMNeuroderm Ltd+0.75+2.60%
RTRXRetrophin Inc+0.28+1.42%
SGMOSangamo Therapeutics...+0.10+1.09%
EPZMEpizyme Inc+1.05+7.69%
Data as of 3:59pm ET, 06/23/2017

Financials

Next reporting dateAugust 14, 2017
EPS forecast (this quarter)-$1.36
Annual revenue (last year)$190.1M
Annual profit (last year)-$127.3M
Net profit margin-66.98%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Denny M. Lanfear
Chief Financial Officer
Jean-Frédéric Viret
Corporate headquarters
Redwood City, California

Forecasts